Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Locemia Solutions

www.locemia.com

Latest From Locemia Solutions

Keeping Track: US FDA Clears Two More Biosimilars, First Non-Injectable Glucagon

The latest drug development news and highlights from our US FDA Performance Tracker.

Approvals Drug Review

BioVentures Raises $87m For Medtech-Dedicated Fund

BioVentures Investors is to invest in early stage medical device and diagnostics companies after closing its fourth – and largest – fund.

Financing StartUps and SMEs

Lilly Diabetes Extends Feelers Into Other Diseases

Eli Lilly leads the way in diabetes and is using its current portfolio to find advantageous opportunities in related therapeutic areas.

BioPharmaceutical Clinical Trials

Lilly Diabetes Extends Feelers Into Other Diseases

Eli Lilly leads the way in diabetes and is using its current portfolio to find advantageous opportunities in related therapeutic areas.

Companies Metabolic Disorders
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Locemia Solutions
  • Senior Management
  • Claude Piché, CEO
    Robert Coburn, CFO
    Martin Lofontaine, Chief Commercial Officer
  • Contact Info
  • Locemia Solutions
    Phone: (844) 562-3642
    8505 Chemin Dalton
    Montreal, H4T 1V5
    Canada
UsernamePublicRestriction

Register